Topics

Articles

PBM transparency and data reporting requirements are likely to be part of a larger healthcare bill that Congress will work on this fall.

Congress Is Expected to Bring PBM Transparency Legislation

Pharma Commerce provides a synopsis of the presentation. 

HDA 2023 Traceability Seminar: GS1 Updates on Implementation Guides

Biopharma company now required to seek approval before attempting further buyouts.

FTC, Amgen Reach Settlement on Dispute Over Horizon Therapeutics Acquisition

Attendees meet to discuss operational issues related to traceability implementation.

HDA 2023 Traceability Seminar: DSCSA Roundtable Discussions

Session offers information on industry readiness, plus an overview of a phase implementation recommendation. 

HDA 2023 Traceability Seminar: DSCSA Areas of Improvement

Pharma Commerce provides a summary of conference breakout session. 

HDA 2023 Traceability Seminar: A Synopsis of FDA’s Enforcement Policies and Guidance Updates

Delay to allow agency to consider other ways of solving the issue, filing says.

Report: FTC Temporarily Suspends Challenge to $27.8B Amgen-Horizon Merger

Illinois Governor JB Pritzker signed into a law a bill prohibiting PBM retaliation against pharmacists who disclose information during government proceedings.

Illinois Governor Signs Legislation Targeting PBM Retaliation

In the midst of providing DSCSA support, the SaaS provider is awarded for being a fast-growing, private US company.

LSPedia Receives Inc. 5000 Ranking Honor

Company will focus on its managed access services.

Legal and Regulatory